Task: Answer the multiple-choice question.
Query: Which drug exhibits a -21.502% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) CCC(C)(C)NC(=O)C(OC(=O)c1ccco1)c1ccccc1F
b) O=C(CN1CCN(S(=O)(=O)c2ccc(Cl)s2)CC1)N1CCCCC1
Answer: b. O=C(CN1CCN(S(=O)(=O)c2ccc(Cl)s2)CC1)N1CCCCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CN1CCN(S(=O)(=O)c2ccc(Cl)s2)CC1)N1CCCCC1
O=C(CN1CCN(S(=O)(=O)c2ccc(Cl)s2)CC1)N1CCCCC1
2-[4-(5-chlorothiophen-2-yl)sulfonylpiperazin-1-yl]-1-piperidin-1-ylethanone